Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis

被引:0
|
作者
Rune V. Overgaard
Kristin C. Petri
Lisbeth V. Jacobsen
Christine B. Jensen
机构
[1] Novo Nordisk A/S,
来源
Clinical Pharmacokinetics | 2016年 / 55卷
关键词
Weight Management; Liraglutide; Orlistat; Population Pharmacokinetic Model; Population Pharmacokinetic Analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1413 / 1422
页数:9
相关论文
共 50 条
  • [1] Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
    Overgaard, Rune V.
    Petri, Kristin C.
    Jacobsen, Lisbeth V.
    Jensen, Christine B.
    CLINICAL PHARMACOKINETICS, 2016, 55 (11) : 1413 - 1422
  • [2] A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
    Pi-Sunyer, Xavier
    Astrup, Arne
    Fujioka, Ken
    Greenway, Frank
    Halpern, Alfredo
    Krempf, Michel
    Lau, David C. W.
    le Roux, Carel W.
    Violante Ortiz, Rafael
    Jensen, Christine Bjorn
    Wilding, John P. H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (01): : 11 - 22
  • [3] Exposure-response analyses of liraglutide 3.0 mg for weight management
    Wilding, J. P. H.
    Overgaard, R. V.
    Jacobsen, L. V.
    Jensen, C. B.
    le Roux, C. W.
    DIABETES OBESITY & METABOLISM, 2016, 18 (05): : 491 - 499
  • [4] Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects
    Bays, Harold
    Pi-Sunyer, Xavier
    Hemmingsson, Joanna Udden
    Claudius, Birgitte
    Jensen, Christine B.
    Van Gaal, Luc
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (02) : 225 - 229
  • [5] A randomized controlled trial of liraglutide 3.0 mg for weight management in adolescents with obesity
    Kelly, Aaron S.
    Auerbach, Pemille
    Barrientos-Perez, Margarita
    Gies, Inge
    Hale, Paula
    Marcus, Claude
    Mastrandrea, Lucy
    Prabhu, Nandana
    Arslanian, Silva A.
    HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 164 - 164
  • [6] Liraglutide 3.0 mg Improves Health Utilities in Weight Management Compared with Placebo
    Bjorner, Jakob B.
    Fujioka, Kenneth
    Le Lay, Agathe
    Brett, Jason
    Kolotkin, Ronette
    DIABETES, 2015, 64 : A565 - A566
  • [7] Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
    Wharton, Sean
    Liu, Aiden
    Pakseresht, Arash
    Nortoft, Emil
    Haase, Christiane L.
    Mancini, Johanna
    Power, G. Sarah
    Vanderlelie, Sarah
    Christensen, Rebecca A. G.
    OBESITY, 2019, 27 (06) : 917 - 924
  • [8] Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland
    Haase, Christiane Lundegaard
    Serratore Achenbach, Maria Giovanna
    Lucrezi, Gianluca
    Jeswani, Nikita
    Maurer, Susanne
    Egermann, Ulrich
    OBESITY FACTS, 2021, 14 (05) : 568 - 576
  • [9] Semaglutide 2.4 mg vs Liraglutide 3.0 mg for Weight Management in Overweight or Obesity (STEP 8)
    Rubino, Domenica
    Greenway, Frank
    Khalid, Usman
    O'Neil, Patrick
    Rosenstock, Julio
    Sorrig, Rasmus
    Wadden, Thomas
    Wizert, Alicja
    Garvey, W. Timothy
    OBESITY, 2021, 29 : 35 - 35
  • [10] REAL-WORLD CLINICAL EFFECTIVENESS OF LIRAGLUTIDE 3.0 MG FOR WEIGHT MANAGEMENT IN CANADA
    Wharton, S.
    Liu, A.
    Pakseresht, A.
    Nortoft, E.
    Haase, C. L.
    Mancini, J.
    Power, G. S.
    VanderLelie, S.
    Christensen, R. A.
    VALUE IN HEALTH, 2018, 21 : S246 - S246